» Authors » Tomas Vega

Tomas Vega

Explore the profile of Tomas Vega including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 24
Citations 462
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Gherasim A, Pozo F, de Mateo S, Gamarra I, Garcia-Cenoz M, Vega T, et al.
Vaccine . 2016 Mar; 34(20):2371-7. PMID: 27020713
Introduction: The 2014/15 influenza season in Spain was dominated by the circulation of drifted A(H3N2) and co-circulation of B viruses. We present the final estimates of influenza vaccine effectiveness (IVE)...
12.
Sanz I, Rojo S, Eiros J, Tamames S, Vega T, Ortiz de Lejarazu R
J Clin Virol . 2015 Nov; 73:52-54. PMID: 26546876
No abstract available.
13.
Sanz I, Tamames S, Rojo S, Justel M, Lozano J, Disdier C, et al.
Adv Virol . 2015 Jun; 2015:560679. PMID: 26064118
Viral infections are one of the main causes of acute exacerbations of chronic obstructive pulmonary disease (AE-COPD). Emergence of A/H1N1pdm influenza virus in the 2009 pandemic changed the viral etiology...
14.
Vega T, Lozano J, Meerhoff T, Snacken R, Beaute J, Jorgensen P, et al.
Influenza Other Respir Viruses . 2015 Jun; 9(5):234-46. PMID: 26031655
Objectives: Although influenza-like illnesses (ILI) and acute respiratory illnesses (ARI) surveillance are well established in Europe, the comparability of intensity among countries and seasons remains an unresolved challenge. The objective...
15.
Fernandez-Berges D, Consuegra-Sanchez L, Penafiel J, de Leon A, Vila J, Felix-Redondo F, et al.
Rev Esp Cardiol (Engl Ed) . 2014 Jul; 67(8):624-31. PMID: 25037541
Introduction And Objectives: There is a paucity of data regarding the differences in the biomarker profiles of patients with obesity, metabolic syndrome, and diabetes mellitus as compared to a healthy,...
16.
Vega T, Gil M, Lozano J
J Diabetes . 2014 Jul; 7(3):411-7. PMID: 24981073
Background: The prevalence of diabetes mellitus (DM) in Spain ranges between 10% and 20%. However, very little is known about the incidence of DM because of difficulties involved in estimating...
17.
Jimenez-Jorge S, de Mateo S, Delgado-Sanz C, Pozo F, Casas I, Garcia-Cenoz M, et al.
BMC Infect Dis . 2013 Sep; 13:441. PMID: 24053661
Background: In Spain, the influenza vaccine effectiveness (VE) was estimated in the last three seasons using the observational study cycEVA conducted in the frame of the existing Spanish Influenza Sentinel...
18.
Vega T, Lozano J, Meerhoff T, Snacken R, Mott J, Ortiz de Lejarazu R, et al.
Influenza Other Respir Viruses . 2012 Aug; 7(4):546-58. PMID: 22897919
Background: Timely influenza surveillance is important to monitor influenza epidemics. Objectives: (i) To calculate the epidemic threshold for influenza-like illness (ILI) and acute respiratory infections (ARI) in 19 countries, as...
19.
Hauswirth A, Almeida J, Nieto W, Teodosio C, Rodriguez-Caballero A, Romero A, et al.
Am J Hematol . 2012 Jun; 87(7):721-4. PMID: 22685020
Monoclonal B-cell lymphocytosis (MBL) with normal lymphocyte counts is associated with decreased numbers of normal circulating B-cell subsets.Little is known about the distribution of normal lymphoid cells and their subsets...
20.
Savulescu C, Jimenez-Jorge S, de Mateo S, Pozo F, Casas I, Brena P, et al.
BMC Public Health . 2011 Dec; 11:899. PMID: 22129083
Background: Physicians of the Spanish Influenza Sentinel Surveillance System report and systematically swab patients attended to their practices for influenza-like illness (ILI). Within the surveillance system, some Spanish regions also...